Targeting HER2 in prostate cancer: Where to next? Journal Article

  

Authors:	Solit, D. B.; Rosen, N.
Article Title:	Targeting HER2 in prostate cancer: Where to next?
Keywords:	gene mutation; genetics; erlotinib; note; metabolism; proto oncogene; enzyme inhibition; ovary cancer; breast cancer; gene amplification; epidermal growth factor receptor; epidermal growth factor receptor 2; lung cancer; editorial; receptor, epidermal growth factor; cetuximab; monoclonal antibody; panitumumab; prostate cancer; prostatic neoplasms; antibodies, monoclonal; colon cancer; prostate tumor; phosphatidylinositol 3,4,5 trisphosphate 3 phosphatase; gefitinib; ras protein; receptor, erbb-2; conformational transition; trastuzumab; genes, erbb-2; b raf kinase; lapatinib; pertuzumab
Journal Title:	Journal of Clinical Oncology
Volume:	25
Issue:	3
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2007-01-20
Start Page:	241
End Page:	243
Language:	English
DOI:	10.1200/jco.2006.08.8187
PUBMED:	17235040
PROVIDER:	scopus
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-33846927015&partnerID=40&md5=a4120f818a8e16ed5518bd26b16baca0
Notes:	--- - "Cited By (since 1996): 12" - "Export Date: 17 November 2011" - "CODEN: JCOND" - "Source: Scopus"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/18309